BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Apr 27, 2026; 18(4): 113354
Published online Apr 27, 2026. doi: 10.4240/wjgs.v18.i4.113354
Table 1 Baseline data comparison: Intervention vs control groups, n (%)/median (interquartile range)

Before the PSM
After the PSM
Variable
Blocking (n = 87)
Non-blocking (n = 133)
Test statistic
P value
Variable
Blocking (n = 87)
Non-blocking (n = 79)
Test statistic
Age (years), mean ± SD45.92 ± 9.9746.54 ± 10.06t = -0.4500.65345.92 ± 9.9744.77 ± 9.40t = -0.7610.448
Genderχ2 = 1.1880.276χ2 = 0.5580.455
    Male24 (27.59)46 (34.59)26 (32.91)24 (27.59)
    Female63 (72.41)87 (65.41)53 (67.09)63 (72.41)
Maximum tumor diameter (cm)6.300 (5.4, 7.3)6.500 (6.0, 8.0)-2.7420.006a7.000 (5.0, 7.8)6.500 (6.0, 8.0)Z = -1.8680.062
Number of tumors5.8040.016aZ = 0.020.888
    142 (48.28)86 (64.66)42 (48.28)39 (49.37)
    ≥ 245 (51.72)47 (35.34)45 (51.72)40 (50.63)
Location0.2030.652Z = 0.6110.434
    Left liver28 (32.18)39 (29.32)28 (32.18)30 (37.97)
    Right liver59 (67.82)94 (70.68)59 (67.82)49 (62.03)
Adjacent blood vessels (cm)2.700 (2.1, 3.1)2.800 (2.3, 3.5)-2.6270.009a2.700 (2.1, 3.1)2.600 (2.1, 3.1)Z = -0.0970.923
ALT (U/L)16.000 (12.0, 26.0)18.000 (12.0, 27.0)-0.7840.43316.000 (12.0, 26.0)17.000 (11.0, 29.0)Z = -0.5290.597
AST (U/L)18.000 (15.0, 24.0)19.000 (16.0, 22.5)-0.9070.36418.000 (15.0, 24.0)19.000 (15.0, 24.0)Z = -1.0390.299
TBIL (μmol/L)10.300 (7.9, 13.1)11.600 (8.0, 14.9)-1.4310.15210.300 (7.9, 13.1)11.700 (7.9, 14.9)Z = -1.3580.174
IBIL (μmol/L)7.700 (5.5, 10.1)8.400 (5.7, 10.6)-0.790.437.700 (5.5, 10.1)7.900 (5.5, 10.4)Z = -0.220.826


Write to the Help Desk